Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
14 results
- 1/2상모집 예정· B-cell Acute Lymphoblastic LeukemiaB-ALL에서 이노투주맙과 블리나투모맙 병용
A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
협력: 암젠, 화이자
- 1/2상모집 중단 (진행 중)· B-cell Acute Lymphoblastic LeukemiaA Phase 1b/2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
협력: 암젠
- 1/2상모집 중단 (진행 중)· Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic LeukemiaA Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
리드: 암젠
- 1/2상모집 중· MelanomaRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
협력: 암젠
- 1/2상모집 중단 (진행 중)· Thyroid Eye DiseaseA Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease
리드: 암젠
- 1/2상모집 중· Lymphoblastic LeukemiaTINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
협력: 암젠
- 1/2상모집 중단 (진행 중)· Non Small Cell Lung CancerPhase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients
협력: 암젠
- 1/2상모집 중단 (진행 중)· Advanced MTAP-null Solid TumorsA Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)
리드: 암젠
- 1/2상모집 중단 (진행 중)· Multiple MyelomaStudy of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
협력: 암젠, GSK
- 1/2상모집 중단 (진행 중)· B Cell Precursor Acute Lymphoblastic LeukemiaA Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
리드: 암젠
- 1/2상모집 중단 (진행 중)· Acute Lymphoblastic LeukemiaA Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance
협력: 암젠
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.